
Gynaia
AI-driven tools and training for gynecological care, enhancing diagnostic accuracy and professional development.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | €2.3m | Seed | |
Total Funding | 000k |
Related Content
Gynaia specializes in providing AI-driven tools and training for gynecological care, focusing on improving diagnostic accuracy and professional development for medical professionals. The company serves gynecologists, sonographers, and clinicians by offering clinical decision support tools, continuous learning opportunities, and networking platforms. Operating in the healthcare sector, Gynaia's business model revolves around Software as a Medical Device (SaMD) solutions, which generate revenue through subscriptions and partnerships. The ADNEX app, a key product, aids clinicians in assessing adnexal masses, leveraging the internationally validated ADNEX model to enhance diagnostic performance. Gynaia's platform also facilitates professional growth through webinars, case studies, and expert-led sessions, fostering a community of over 15,000 professionals. By integrating real-time data analysis and actionable feedback, Gynaia empowers healthcare providers to deliver high-quality care and advance healthcare accessibility.